11/26/24 RadUnity was 510(k) Class II medical device cleared

RadUnity
RadUnity
  • Home
  • Team
  • Investors
  • Contact

Company Overview

See RadUnity's Informational Brochure for more information. 


RadUnity offers a customizable platform that harmonizes images from diverse data to address clinical variability and healthcare provider burnout. Founded in 2023, RadUnity’s Software as a Service (SaaS) presents an innovative and efficient solution to CT image variability to ensure uniformity and consistency in imaging data interpretation. The company’s mission  is to enhance accuracy and efficiency in data interpretation while providing a customizable toolkit that supports and empowers radiologists and AI CADe/x solutions.

RadUnity Trajectory

 Founded in December 2022, RadUnity quickly progressed from concept to execution. We secured $500K in pre-seed funding by July 2023 and became a qualified new business venture in Wisconsin by September 2023. Our Quality Management System was implemented in March 2024, followed by a $75K New Technology Development Loan from the State of Wisconsin in July. By summer 2024, we validated our solution with radiologists and technologists, submitted a $310K NSF SBIR grant, and achieved FDA clearance for our product in November. 


In just 16 months, RadUnity used $500K in pre-seed funding to develop and receive FDA clearance. 


Current Investors

With the trust and support of generous investors, the company is making significant strides in developing a platform that will radically improve the field of medical image harmonization for physicians and the AI engines that augment their patient care efforts. 


Investors in RadUnity demonstrate impressive backgrounds in entrepreneurship and healthcare. Notably, key investors possess extensive backgrounds in radiology and medical imaging. Those working in the field are uniquely qualified to comprehend the daily hurdles encountered by radiologists and fully grasp the transformative possibilities of this company’s normalization platform.

RadUnity has the status* of a Qualified New Business Venture (QNBV). This Program offers incentives for investment in early-stage Wisconsin businesses with the potential for significant economic impact and job growth. This program creates mutually beneficial outcomes for investors**, businesses and Wisconsin’s economy. 

 *The Wisconsin Economic Development Corporation (WEDC) does not endorse the quality of management or the potential for earnings for the certified Qualified New Business Venture. Furthermore, the Qualified New Business Venture’s use of the phrase “certified” and/or “qualified new business venture” is not a recommendation or endorsement of the investment or the company by WEDC.

**Certification of a fund by WEDC is not an endorsement of the quality of management of that fund. WEDC is not liable for damages or losses to an investor.

RadUnity utilizes IP* owned by the Wisconsin Alumni Research Foundation (WARF). WARF  is a non-profit associated with the University of Wisconsin-Madison that helps steward the cycle of research, discovery, commercialization and investment for UW faculty, staff, and students. 


* "System for Harmonizing Medical Imaging Presentation" USTPO Patent 10964074

News

Check out Dr. Szczykutowicz's podcast interview about RadUnity's recent FDA clearance with WisBusiness here!

RadUnity Solution Receives FDA 510(k) Clearance as a Class II Medical Device (pdf)Download
Greater Madison Chamber of Commerce Announces 2023 Pressure Chamber Finalists (pdf)Download
RadUnity Secures $500k in Seed Funding to Revolutionize Data Normalization for Healthcare Providers (pdf)Download

The name RadUnity™  is legally trademarked through The United States Patent and Trademark Office (USPTO), granting RadUnity Corp. full ownership of and authorizing company use of name and mark in commerce related to associated products and services.

Copyright © 2022 RadUnity Corp. - All Rights Reserved.

  • Home
  • Team
  • Investors

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept